Pe Analytics Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 12, 2026

Key Highlights

The Latest Trading Price of P.E. Analytics Ltd is ₹ 179 as of 12 Mar 15:30 . The P/E Ratio of P.E. Analytics Ltd changed from 15.3 on March 2023 to 18.5 on March 2025 . This represents a CAGR of 6.54% over 3 yearsThe P/E Ratio of Sheel Biotech Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 years The Market Cap of P.E. Analytics Ltd changed from ₹ 157.6 crore on March 2023 to ₹ 238.99 crore on March 2025 . This represents a CAGR of 14.89% over 3 yearsThe Market Cap of Sheel Biotech Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 years The Dividend Payout of P.E. Analytics Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About P.E. Analytics Ltd

P.E. Analytics Limited was incorporated on January 08, 2008 as a Private Company with the Registrar of Companies, Delhi as P. E. Analytics Private Limited'.
Subsequently, the status of the Company got converted into Public Company and fresh Certificate of Incorporation dated February 08, 2022 was issued to the Company by the Registrar of Companies, Delhi. PropEquity is India's largest Real Estate Data & Analytics company and listed on the NSE Stock Exchange as P.E. Analytics Limited.
PropEquity was founded on a visionary premise to address the challenges of large investments in an unstructured & opaque real estate environment that lacked realtime data. The Company is engaged in providing proprietary Real Estate Business Intelligence and Analytics platform on B2B business model to various users such as developers, construction industry, investors, banks, housing finance companies, equity research firms, real estate PE funds, REIT's, financial institutions, Mortgage Insurers, HNIs, Lenders and Investors in real estate.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of P.E. Analytics Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, P.E. Analytics Ltd or Sheel Biotech Ltd?

Market cap of P.E. Analytics Ltd is 187 Cr while Market cap of Sheel Biotech Ltd is 110 Cr

What are the key factors driving the stock performance of P.E. Analytics Ltd and Sheel Biotech Ltd?

The stock performance of P.E. Analytics Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for P.E. Analytics Ltd and Sheel Biotech Ltd?

As of March 12, 2026, the P.E. Analytics Ltd stock price is INR ₹179.0. On the other hand, Sheel Biotech Ltd stock price is INR ₹54.5.

How do dividend payouts of P.E. Analytics Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of P.E. Analytics Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.